General
Experience9 yrs
Elite Ratings
--
Practice Areas
Biotech (22 cases)
Transport., E-Comm. (2 cases)
Reexam/Aband. (2 cases)
Ratings
Experience
Grade
Trend
DCT
L1
E
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:23-CV-01196 | Bayer Pharma AG v. Cipla Ltd | 10/20/23 | Challenger | |
| 1:23-CV-01190 | ZS Pharma Inc v. Macleods Pharma Ltd | 10/20/23 | Challenger | |
| 1:23-CV-00665 | Bayer Pharma AG v. Macleods Pharma Ltd | 06/16/23 | Challenger | |
| 1:22-CV-01100 | ZS Pharma Inc v. Macleods Pharma Ltd | 08/22/22 | Challenger | |
| 1:22-CV-01055 | ZS Pharma Inc v. Lupin Ltd | 08/10/22 | Challenger | |
| 1:22-CV-00696 | Aragon Pharma Inc v. Hetero USA Inc | 05/27/22 | Challenger | |
| 1:21-MD-03017 | In re: Xarelto (Rivaroxaban) ('310) Patent Litigation | 12/10/21 | ||
| 1:21-CV-01350 | PF Prism Imb BV v. Macleods Pharmaceuticals | 09/24/21 | Challenger | |
| 1:21-CV-01348 | Anacor Pharma LLC v. DR Reddys Laboratories Ltd | 09/24/21 | Challenger | |
| 1:21-CV-01330 | Novartis Pharma Corp v. Torrent Pharma Inc | 09/20/21 | Challenger |